Dividends CalendarEarnings Calendar
TROV

TROV | TrovaGene, Inc.

TrovaGene, Inc.
  • Industry: Biotechnology

Quick infos

  • Headquarters:   California, United States

Trade prices

  • Volume: 1.7M
  • Market Cap: 13.65M
  • Prev closed: 1.72
  • Open: 2.05
  • High: 2.08
  • Low: 1.8
  • 52 week low: 0.88
  • 52 week high: 9.65
  • Dividends:

Next ER: May 5, 2020 



Top Stories (TROV)

    Company Profile

    Trovagene is a clinical-stage, oncology therapeutics company, taking a precision medicine approach and integrating a biomarker strategy to develop targeted drugs to treat leukemias, lymphomas and solid tumor cancers. Our drug candidate, onvansertib, is a first-in-class, 3rd generation Polo-like Kinase Inhibitor with best-in-class attributes. Onvansertib is highly-selective for PLK1, which is over-expressed in most cancers; it is orally administered; synergistic in combination with numerous chemotherapies and targeted therapeutics; has a half-life of 24-hours which allows for flexibility in dosing and schedule. We are developing onvansertib as part of combination regimens with already approved drugs for the treatment of cancers and indications where there is a significant medical need for new treatment options.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    March 12, 2020- / -0.58- / 203K
    November 7, 2019-0.71 / -0.8452K / 195K
    August 8, 2019-0.79 / -1.02138K / 180K
    May 7, 2019-1.02 / -1.07162K / 173K
    March 6, 2019-1.09 / -1.0578K / 107K
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Sep 30, 2020 14.980 14.740
    15.930
    14.500
    2.18M 6.92%
    Sep 29, 2020 14.010 12.200
    15.200
    12.200
    4.47M 15.02%
    Sep 28, 2020 12.180 11.700
    12.330
    11.220
    931.65K 7.03%
    Sep 25, 2020 11.380 10.800
    11.600
    10.290
    703.96K 6.26%
    Sep 24, 2020 10.710 11.000
    11.150
    10.210
    1.04M -5.64%
    Sep 23, 2020 11.350 11.515
    12.280
    10.830
    2.48M -3.07%
    Sep 22, 2020 11.710 10.820
    11.710
    10.130
    3.14M 0.95%
    Sep 21, 2020 11.600 8.920
    11.840
    8.920
    19.23M 33.18%
    Sep 18, 2020 8.710 8.470
    9.100
    8.080
    6.42M 7.40%
    Sep 17, 2020 8.110 6.110
    11.070
    5.890
    47.46M 39.59%
    view more
    NASDAQ - Nasdaq Stock Market

    News

    News for (TROV)


    Talk about TrovaGene, Inc. below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on May 5, 2020 (Same day)

    ftr 


    Jump to (Finance sites)

    Their Official Profiles 

    TwitterLinkedIn

    Peers / Similar stocks 

    xlv 

    Other stocks 

    csco crm adsk abbv bac swn cag mrk chl kr agn keys 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Technical Analysis For Dummies
    Buy on Amazon

    Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.

    A simple, straightforward guide to the fundamentals of technical analysis